Mirae Asset Global Investments Co., Ltd. Collegium Pharmaceutical, Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,075 shares of COLL stock, worth $32,809. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,075
Previous 1,165
7.73%
Holding current value
$32,809
Previous $45,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding COLL
# of Institutions
248Shares Held
37.5MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$177 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$80.4 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$71.6 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$65.4 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$50.5 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.04B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...